BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND CEACAM5, CEA
2493 results:

  • 1. Single-sEV profiling identifies the TACSTD2 + sEV subpopulation as a factor of tumor susceptibility in the elderly.
    Ning N; Lu J; Li Q; Li M; Cai Y; Wang H; Li J
    J Nanobiotechnology; 2024 May; 22(1):222. PubMed ID: 38698420
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Single-cell analysis revealed a potential role of T-cell exhaustion in colorectal cancer with liver metastasis.
    Ling T; Zhang C; Liu Y; Jiang C; Gu L
    J Cell Mol Med; 2024 Apr; 28(8):e18341. PubMed ID: 38647235
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prognostic factors associated with early recurrence following liver resection for colorectal liver metastases: a systematic review and meta-analysis.
    Tian Y; Wang Y; Wen N; Wang S; Li B; Liu G
    BMC Cancer; 2024 Apr; 24(1):426. PubMed ID: 38584263
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clinical study on simultaneous resection of liver metastases combined with hyperthermic intraperitoneal chemotherapy for synchronous colorectal cancer liver metastasis.
    Li W; Ren H; Mou H; Li J; Dong L; Li G; Xing M
    J Gastrointest Surg; 2024 Apr; 28(4):425-433. PubMed ID: 38583892
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Performance of Intracystic Glucose Measurement for the Characterization of Pancreatic Cystic Lesions.
    Ribeiro T; Lopes S; Moutinho-Ribeiro P; Macedo G; Vilas-Boas F
    J Gastrointestin Liver Dis; 2024 Mar; 33(1):74-78. PubMed ID: 38554431
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Initial presentation of hepatocellular carcinoma as pharyngeal mass mimicking advanced hypopharyngeal carcinoma.
    Sukumaran R; Kattoor J; Valsalamony J; Varghese BT
    J Cancer Res Ther; 2024 Jan; 20(1):438-440. PubMed ID: 38554358
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Tumor burden score and carcinoembryonic antigen predict outcomes in patients with intrahepatic cholangiocarcinoma following liver resection: a multi‑institutional analysis.
    Fu J; Zheng L; Tang S; Lin K; Zheng S; Bi X; Wang J; Guo W; Li F; Wang J; Wang K; Li H; Zeng Y
    BMC Cancer; 2024 Mar; 24(1):358. PubMed ID: 38509498
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Predictive nomograms of repeat intrahepatic recurrence and overall survival after radiofrequency ablation of recurrent colorectal liver metastases.
    Wang JC; Jiang BB; Zhang ZY; Liu YH; Shao LJ; Wang S; Yang W; Wu W; Yan K
    Int J Hyperthermia; 2024; 41(1):2323152. PubMed ID: 38465646
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Development of a Serum-Based MicroRNA Signature for Early Detection of Pancreatic cancer: A Multicenter Cohort Study.
    Huang J; Gao G; Ge Y; Liu J; Cui H; Zheng R; Wang J; Wang S; Go VL; Hu S; Liu Y; Yang M; Sun Y; Shang D; Tian Y; Zhang Z; Xiang Z; Wang H; Guo J; Xiao GG
    Dig Dis Sci; 2024 Apr; 69(4):1263-1273. PubMed ID: 38451429
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Long-Term Suppression with First-Line Chemotherapy(FOLFIRI plus BV)for Peritoneal Metastasis].
    Teranishi N; Inagaki S; Yoshida H; Nagasawa S; Takane Y; Yan M; Takahashi M; Masubuchi M; Wakabayashi K; Uetake H; Itoh Y
    Gan To Kagaku Ryoho; 2024 Feb; 51(2):199-201. PubMed ID: 38449412
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The oncologic outcome and prognostic factors for solitary colorectal liver metastasis after liver resection.
    Hsu YJ; Chern YJ; Wu ZE; Yu YL; Liao CK; Tsai WS; You JF; Lee CW
    J Gastrointest Surg; 2024 Mar; 28(3):267-275. PubMed ID: 38445919
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Development and validation of comprehensive nomograms from the SEER database for predicting early mortality in metastatic rectal cancer patients.
    Li Y; Tao T; Liu Y
    BMC Gastroenterol; 2024 Feb; 24(1):89. PubMed ID: 38408896
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A pair of primary colorectal cancer-derived and corresponding synchronous liver metastasis-derived organoid cell lines.
    Cheng F; Li P; Xu S; Zhang C; Liang H; Ding Z
    Aging (Albany NY); 2024 Feb; 16(5):4396-4422. PubMed ID: 38407980
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Non-metastatic colon cancer: French Intergroup Clinical Practice Guidelines for diagnosis, treatments, and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNIcancer, SFCD, SFED, SFRO, ACHBT, SFP, AFEF, and SFR).
    Lecomte T; Tougeron D; Chautard R; Bressand D; Bibeau F; Blanc B; Cohen R; Jacques J; Lagasse JP; Laurent-Puig P; Lepage C; Lucidarme O; Martin-Babau J; Panis Y; Portales F; Taieb J; Aparicio T; Bouché O; ; ; ; ; ; ; ; ; ; ; ;
    Dig Liver Dis; 2024 May; 56(5):756-769. PubMed ID: 38383162
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [liver transplantation for treatment of nonresectable primary and secondary liver malignancies : Hepatocellular and cholangiocellular carcinomas and colorectal liver metastases].
    Guba M; Werner J
    Chirurgie (Heidelb); 2024 Apr; 95(4):268-273. PubMed ID: 38329517
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Obinutuzumab Pretreatment as a Novel Approach to Mitigate Formation of Anti-Drug Antibodies Against Cergutuzumab Amunaleukin in Patients with Solid Tumors.
    Peters S; Angevin E; Alonso-Gordoa T; Rohrberg K; Melero I; Mellado B; Perez-Gracia JL; Tabernero J; Adessi C; Boetsch C; Watson C; Dal Porto J; Dejardin D; Del Nagro C; Nicolini V; Evers S; Klein C; Leutgeb B; Pisa P; Rossmann E; Saro J; Umana P; Charo J; Teichgräber V; Steeghs N
    Clin Cancer Res; 2024 Apr; 30(8):1630-1641. PubMed ID: 38319672
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [A Case of Long-Term Survival with Metachronous Hepatic and Pulmonary Metastases from Transverse Colon cancer by Multidisciplinary Treatment].
    Hara T; Okano M; Hata T; Takayama O; Kim Y; Imamoto H; Hasegawa J
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1857-1859. PubMed ID: 38303231
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Normal cea Levels After Neoadjuvant Chemotherapy and Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion Predict Improved Survival from Colorectal Peritoneal Metastases.
    Wach MM; Nunns G; Hamed A; Derby J; Jelinek M; Tatsuoka C; Holtzman MP; Zureikat AH; Bartlett DL; Ahrendt SA; Pingpank JF; Choudry MHA; Ongchin M
    Ann Surg Oncol; 2024 Apr; 31(4):2391-2400. PubMed ID: 38270826
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Immunotherapy in mismatch repair-deficient metastatic colorectal cancer - Outcome and novel predictive markers.
    Stemmer A; Margalit O; Serpas V; Strauss G; Thomas J; Shah P; Tau N; Levanon K; Shacham-Shmueli E; Kopetz S; Overman M; Boursi B
    Eur J Cancer; 2024 Feb; 198():113495. PubMed ID: 38157568
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Integrated plasma metabolomics and lipidomics profiling highlights distinctive signature of hepatocellular carcinoma in HCV patients.
    Caponigro V; Tornesello AL; Merciai F; La Gioia D; Salviati E; Basilicata MG; Musella S; Izzo F; Megna AS; Buonaguro L; Sommella E; Buonaguro FM; Tornesello ML; Campiglia P
    J Transl Med; 2023 Dec; 21(1):918. PubMed ID: 38110968
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 125.